Tevogen Bio CFO gifts 300,000 company shares to charities

Tevogen Bio Holdings Inc.'s Chief Financial Officer reported gifting 300,000 shares of common stock in a recent insider transaction.

Rhea-AI Filing Summary

Tevogen Bio Holdings Inc.'s Chief Financial Officer reported gifting 300,000 shares of common stock in a recent insider transaction.

The filing states that 100,000 shares were donated to Shrimad Rajchandra Love and Care USA, Inc. and 200,000 shares to Shrimad Rajchandra Mission Dharampur (USA), Inc., both described as charitable entities. Following these gifts, the reporting person beneficially owns 10,149,186 shares of Tevogen Bio common stock directly.

Insider Trade Summary

300,000 shares gifted

Gift 1 txn

Insider Desai Kirti

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Gift	Common Stock	300,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 10,149,186 shares (Direct)

Footnotes (1)

1. F1. Represents a gift of 100,000 shares of common stock to Shrimad Rajchandra Love and Care USA, Inc. and 200,000 shares of common stock to Shrimad Rajchandra Mission Dharampur (USA), Inc., which are charitable entities.

FAQ

What insider transaction did Tevogen Bio Holdings Inc. (TVGN) report for its CFO?

The Chief Financial Officer of Tevogen Bio Holdings Inc. reported a transaction in which 300,000 shares of the company’s common stock were gifted to charitable entities.

How many Tevogen Bio (TVGN) shares did the CFO donate and to which organizations?

The filing notes a gift of 300,000 shares in total: 100,000 shares to Shrimad Rajchandra Love and Care USA, Inc. and 200,000 shares to Shrimad Rajchandra Mission Dharampur (USA), Inc., both described as charitable entities.

On what date did the Tevogen Bio (TVGN) stock gift by the CFO occur?

The reported gift of Tevogen Bio common stock by the CFO took place on 12/11/2025, according to the transaction date in the filing.

How many Tevogen Bio (TVGN) shares does the CFO own after the reported gift?

After completing the 300,000-share gift, the Chief Financial Officer is shown as beneficially owning 10,149,186 shares of Tevogen Bio common stock directly.

Was the Tevogen Bio (TVGN) CFO’s transaction a sale for cash or a gift?

The transaction is coded as a gift, with 300,000 shares disposed of at a reported price of $0, and the explanation describes transfers to charitable entities.

What type of security was involved in the Tevogen Bio (TVGN) CFO’s transaction?

The reported transaction involved common stock of Tevogen Bio Holdings Inc., as listed in the non-derivative securities table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/15/2025 - 05:31 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Desai Kirti

(Last) (First) (Middle)

C/O TEVOGEN BIO HOLDINGS INC.

15 INDEPENDENCE BLVD, STE 210

(Street)

WARREN NJ 07059

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Tevogen Bio Holdings Inc. [ TVGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/11/2025		G(1)		300,000	D	$0	10,149,186	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a gift of 100,000 shares of common stock to Shrimad Rajchandra Love and Care USA, Inc. and 200,000 shares of common stock to Shrimad Rajchandra Mission Dharampur (USA), Inc., which are charitable entities.

	/s/ Kirti Desai	12/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.